How is the Biogen Inc today?

The Biogen Inc today is trading in the green, up by 5.27% at 124.40.

How has Biogen Inc performed historically?

The Biogen Inc is currently trading up 5.27% on an intraday basis in the past week the index rose 0.70%. The index has been down -10.75% in the past quarter and fell -43.84% in the past year. You can view this in the overview section.

What is Biogen Inc Annual Revenue?

Biogen Inc Annual Revenue fell 1.62%, in the last year to $9,675.9 M. Its sector's average revenue growth for the last fiscal year was 6.72%.

What is Biogen Inc Annual Net Profit?

Biogen Inc Annual Net Profit rose 40.57% in the last year to $1,632.2 M. Its sector's average net profit growth for the last fiscal year was -42.75%.

What is Biogen Inc Price to Earning Ratio?

Biogen Inc Price to Earning Ratio is 12.32, higher than its sector PE ratio of 3.16.

What is Biogen Inc Stock Price?

Biogen Inc Stock Price fell 43.84% and underperformed its sector by 58.27% in the past year.

What is Biogen Inc Quarterly Revenue?

Biogen Inc Quarterly Revenue rose 6.13% YoY to $2,431 M. Its sector's average revenue growth YoY for the quarter was 4.18%.

What is Biogen Inc Quarterly Net profit?

Biogen Inc Quarterly Net profit fell 38.87% YoY to $240.5 M. Its sector's average net profit growth YoY for the quarter was -40.08%.

What is Biogen Inc Debt to Equity Ratio?

Biogen Inc Debt to Equity Ratio of 0.4 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Biogen Inc Return on Equity(ROE)?

Biogen Inc Return on Equity(ROE) for the last financial year was 10.36%, in the normal range of 10% to 20%.

What is Biogen Inc Mutual Fund Holding?

Biogen Inc Mutual Fund Holding decreased by 1.47% in the last quarter to 72.26.

What is Biogen Inc Interest Coverage Ratio?

Biogen Inc Interest Coverage Ratio is 8.61, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Biogen Inc Institutional Holding?

Biogen Inc Institutional Holding increased by 0.7% in the last quarter to 91.27.

Biogen Inc XNAS: BIIB

Biogen Inc Live Share Price Today, Share Analysis and Chart

Name: Biogen Inc: Is Infosys Ltd. worth buying?
Item: Biogen Inc
Rating: 2.878750125
Author: Trendlyne DVM scores

Value Stock, Under Radar

about

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a colla...

124.40 6.23 (5.27%)

47.73% Fall from 52W High

2.6M XNAS Volume

XNAS 12 May, 2025 4:05 PM (EDT)

High Financial Strength

66.7 / 100

Affordable Valuation

63.7 / 100

Technically Bearish

33.3 / 100

Value Stock, Under Radar These stocks are strong in quality and valuation, but score weak in technical aspects. Hence, it is better to wait for the stock to change their momentum. View Similar Embed DVM

172

1Yr Price target upside is 38%

30 analysts

Biogen Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Biogen Inc Live Share Price Today, Share Analysis and Chart

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a colla...

47.73% Fall from 52W High

SWOT Analysis

Biogen Inc Live Price Chart

Biogen Inc FAQ

How is Biogen Inc today?

Biogen Inc today is trading in the green, and is up by 5.27% at 124.40.

How has Biogen Inc performed historically?

Biogen Inc is currently trading up 5.27% on an intraday basis. In the past week the stock rose 0.70%. stock has been down -10.75% in the past quarter and fell -43.84% in the past year. You can view this in the overview section.